Marcello Di Nisio Selected Research

Inflammation (Inflammations)

1/2023	NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis.
1/2022	Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.
1/2021	Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19.
10/2004	Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcello Di Nisio Research Topics

Disease

52	Neoplasms (Cancer) 05/2024 - 05/2004
51	Hemorrhage 09/2023 - 02/2012
37	Venous Thromboembolism 01/2023 - 05/2004
26	Thrombosis (Thrombus) 03/2024 - 11/2009
11	Venous Thrombosis (Deep-Vein Thrombosis) 09/2023 - 12/2003
8	Disseminated Intravascular Coagulation 07/2020 - 05/2012
8	Sepsis (Septicemia) 07/2020 - 05/2012
7	COVID-19 01/2023 - 11/2020
7	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2021 - 01/2018
5	Pneumonia (Pneumonitis) 01/2023 - 11/2020
5	Pulmonary Embolism 10/2019 - 06/2011
5	Thrombophilia 01/2018 - 12/2003
4	Inflammation (Inflammations) 01/2023 - 10/2004
4	Atrial Fibrillation 12/2022 - 09/2014
4	Cognitive Dysfunction 01/2019 - 09/2014
4	Pain (Aches) 11/2015 - 09/2012
3	Obesity 01/2023 - 09/2002
3	Body Weight (Weight, Body) 05/2021 - 09/2016
3	Multiple Myeloma 12/2020 - 08/2014
3	Dementia (Dementias) 01/2019 - 11/2018
3	Thrombophlebitis 12/2018 - 02/2014
3	Weight Loss (Weight Reduction) 07/2004 - 09/2002
2	Thromboinflammation 09/2023 - 01/2023
2	Frailty 01/2023 - 12/2022
2	Disease Progression 01/2023 - 11/2020
2	Critical Illness (Critically Ill) 02/2022 - 01/2013
2	Myocardial Infarction 02/2022 - 06/2014
2	Infections 01/2022 - 01/2020
2	Upper Extremity Deep Vein Thrombosis 01/2022 - 12/2016
2	Lung Neoplasms (Lung Cancer) 10/2020 - 11/2010
2	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 05/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 05/2011
2	Hypertension (High Blood Pressure) 01/2017 - 09/2002
2	Vomiting 06/2015 - 09/2012
2	Nausea 06/2015 - 09/2012
2	Habitual Abortion (Recurrent Miscarriage) 07/2014 - 01/2009
2	Spontaneous Abortion (Miscarriage) 07/2014 - 01/2009
2	Vascular Remodeling 10/2004 - 06/2002
2	Atherosclerosis 10/2004 - 06/2002
1	Vascular System Injuries 09/2023
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Ischemic Stroke 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Pericarditis 01/2022
1	Short Bowel Syndrome 01/2022
1	Heart Failure 01/2022

Drug/Important Bio-Agent (IBA)

47	AnticoagulantsIBA 05/2024 - 03/2005
29	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 05/2004
14	Vitamin K FDA Link 01/2022 - 05/2004
11	edoxabanIBA 02/2022 - 11/2015
11	Heparin (Liquaemin)FDA LinkGeneric 12/2020 - 03/2005
9	RivaroxabanIBA 02/2022 - 10/2015
8	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 02/2012
8	AntithrombinsIBA 12/2020 - 02/2012
8	Dacarbazine (DIC)FDA LinkGeneric 07/2020 - 05/2012
7	Fondaparinux (Arixtra)FDA Link 06/2023 - 03/2012
7	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 01/2018
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2020 - 01/2007
6	fibrin fragment D (D-dimer)IBA 01/2023 - 04/2014
6	Factor Xa InhibitorsIBA 12/2020 - 08/2014
5	apixabanIBA 01/2023 - 08/2014
5	Enoxaparin (Lovenox)FDA LinkGeneric 01/2022 - 01/2009
4	tocilizumab (atlizumab)FDA Link 10/2022 - 11/2020
4	CytokinesIBA 01/2021 - 06/2002
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 06/2011
3	Colchicine FDA LinkGeneric 09/2023 - 01/2022
3	InflammasomesIBA 09/2023 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 07/2018 - 03/2016
3	LeptinIBA 07/2004 - 09/2002
2	Interleukin-1 (Interleukin 1)IBA 01/2023 - 01/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 02/2022 - 01/2021
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 11/2005
2	ThrombomodulinIBA 01/2020 - 09/2016
2	Vitamin B Complex (B Vitamins)IBA 12/2018 - 11/2018
2	MineralsIBA 12/2018 - 11/2018
2	VitaminsIBA 12/2018 - 11/2018
2	Vitamin E FDA LinkGeneric 12/2018 - 11/2018
2	vinyltriethoxysilane (VTES)IBA 12/2018 - 02/2014
2	semuloparinIBA 12/2016 - 08/2014
2	Nadroparin (Nadroparin Calcium)IBA 07/2014 - 05/2011
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2004 - 09/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2004 - 06/2002
1	canakinumab FDA Link 09/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2023
1	betrixabanIBA 01/2022

Therapy/Procedure

35	Therapeutics 05/2024 - 05/2004
19	Drug Therapy (Chemotherapy) 01/2023 - 11/2010
4	Duration of Therapy 08/2018 - 06/2011
3	Contraindications 11/2020 - 01/2013
2	Catheters 05/2021 - 11/2015
2	Operative Surgical Procedures 01/2021 - 02/2019
2	Central Venous Catheters 12/2016 - 03/2016
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2016 - 08/2015
2	Caloric Restriction 01/2004 - 09/2002
1	Indwelling Catheters (Indwelling Catheter) 01/2022
1	Home Parenteral Nutrition 01/2022